ArticleGeoHealth2021
"Distance-Driven" Versus "Density-Driven": Understanding the Role of "Source-Case" Distance and Gathering Places in the Localized Spatial Clustering of COVID-19-A Case Study of the Xinfadi Market, Beijing (China).
Article in GeoHealth, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Methods Used in the Spatial and Spatiotemporal Analysis of COVID-19 Epidemiology: A Systematic Review.International journal of environmental research and public health · 2022Pooled it
- Spatial-temporal evolution of overweight and obesity among Chinese adolescents from 2016 to 2020.iScience · 2024Article
- Understanding the impact of mobility on COVID-19 spread: A hybrid gravity-metapopulation model of COVID-19.PLoS computational biology · 2023Article
- Do spatiotemporal units matter for exploring the microgeographies of epidemics?Applied geography (Sevenoaks, England) · 2022Article
- A Novel Predictor for Micro-Scale COVID-19 Risk Modeling: An Empirical Study from a Spatiotemporal Perspective.International journal of environmental research and public health · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The frequent occurrence of local COVID-19 today gives a strong necessity to better understand the effects of "source-case" distance and gathering places, which are often considered to be the key factors of the localized spatial clustering of an epidemic. In this study, the localized spatial clustering of COVID-19 cases, which originated in the Xinfadi market in Beijing from June-July 2020, was investigated by exploring the spatiotemporal characteristics of the clustering using descriptive statistics, point pattern analysis, and spatial autocorrelation calculation approaches. Spatial lag zero-inflated negative binomial regression model and geographically weighted Poisson regression with spatial effects were also introduced to explore the factors which influenced the clustering of COVID-19 cases at the micro spatial scale. It was found that the local epidemic can be significantly divided into two stages which are asymmetric in time. A significant spatial spillover effect of COVID-19 was identified in both global and local modeling estimation. The dominant role of the "source-case" distance effect, which was reflected in both global and local scales, was revealed. Relatively, the role of gathering places is not significant at the initial stage of the epidemic, but the upward trend of the significance of some places is obvious. The trend from "distance-driven" to "density-driven" of the localized spatial clustering of COVID-19 was predicted. The effectiveness of blocking the transformation trend will be a key issue for the global response to the local COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.